Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.040
-0.050 (-4.59%)
Nov 21, 2024, 11:32 AM EST - Market open

Cue Biopharma Revenue

Cue Biopharma had revenue of $3.34M in the quarter ending September 30, 2024, with 58.86% growth. This brings the company's revenue in the last twelve months to $9.53M, up 149.53% year-over-year. In the year 2023, Cue Biopharma had annual revenue of $5.49M with 340.96% growth.

Revenue (ttm)
$9.53M
Revenue Growth
+149.53%
P/S Ratio
5.66
Revenue / Employee
$179,849
Employees
53
Market Cap
62.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InterCure 72.42M
Celularity 42.69M
Cryo-Cell International 31.84M
electroCore 23.33M
InspireMD 6.82M
BeyondSpring 1.88M
Monogram Technologies 365.00K
Revenue Rankings